Sunbelt Securities’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Sunbelt Securities’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25	Closed	-$971	–	2767
2025 Q2	$971	Buy	+25	New	+$792	﹤0.01%	1664
2025 Q1	–	Sell	-25	Closed	-$967	–	1845
2024 Q4	$967	Hold	25	–	–	﹤0.01%	1671
2024 Q3	$1.13K	Hold	25	–	–	﹤0.01%	1672
2024 Q2	$1.04K	Hold	25	–	–	﹤0.01%	1612
2024 Q1	$1.14K	Hold	25	–	–	﹤0.01%	1565
2023 Q4	$1.16K	Hold	25	–	–	﹤0.01%	1526
2023 Q3	$1.02K	Hold	25	–	–	﹤0.01%	1585
2023 Q2	$1.21K	Buy	+25	New	+$1.25K	﹤0.01%	1496

Other funds holding GNOM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Sunbelt Securities's GNOM Position: Q3 2025 in Review

Sunbelt Securities sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 25 shares — an estimated $971 sold.

Sunbelt Securities first reported a position in GNOM in Q2 2023 and held it in 8 quarters. The position peaked at $1.21K in Q2 2023. 43 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

Sunbelt Securities reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Sunbelt Securities sold 25 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $971.
Sunbelt Securities first reported a position in Global X Genomics & Biotechnology ETF in Q2 2023 and held it in 8 quarters.
Sunbelt Securities's Global X Genomics & Biotechnology ETF position peaked at $1.21K in Q2 2023.
43 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Sunbelt Securities's 13F filing for Q3 2025, filed 19 Nov 2025.